Altimmune Inc.

NASDAQ: ALT · Real-Time Price · USD
3.56
-0.07 (-1.93%)
At close: Aug 21, 2025, 11:26 AM

Altimmune Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-87.75M -90.24M -95.06M -103.52M -101.35M -92.77M -88.45M -78.47M -81.31M -85.36M -84.71M -86.94M -96.94M -101.66M -97.09M -83.82M -68.08M -60.02M
Depreciation & Amortization
129K 160K 238K 2.1M 1.51M 940K 477K -1.65M -1.24M -680K -205K 148.29K 573.91K 596K 551.3K 513.13K 301.4K 299K
Stock-Based Compensation
14.01M 14.76M 14.39M 13.51M 13.14M 11.62M 10.64M 10.06M 9.48M 8.74M 8.1M 7.53M 6.9M 6.33M 5.52M 4.91M 4.73M 3.58M
Other Working Capital
-6.49M -1K 3.42M 2.38M 7.83M -772K -2.42M -5.9M 2.76M 5.52M 11.11M 6.68M 8.53M 5.91M -5.85M 3.42M -6.66M -5.58M
Other Non-Cash Items
-942K -1.61M -1.88M 8.98M 7.96M 8.84M 9.79M 83K 36K 2.02M 254K 3.14M 5.16M 10.34M 13.03M 3.9M 10.58M 15.38M
Deferred Income Tax
-681K -681K n/a n/a n/a n/a n/a n/a n/a n/a -110K 3.86M 4.14M 12.19M 12.33M 8.39M 8.08M -10.64K
Change in Working Capital
-6.35M -2.72M 2.46M 821K 7.26M -1.39M -8.27M -6.61M 1.89M 6.83M 14.11M 9.01M 14.47M 12.3M -250.53K 4.82M -8.95M -8.9M
Operating Cash Flow
-81.57M -80.33M -79.85M -78.12M -71.48M -72.76M -75.81M -76.58M -71.15M -68.47M -62.59M -67.25M -69.97M -72.19M -78.24M -69.68M -61.41M -49.66M
Capital Expenditures
-10K n/a n/a n/a n/a 4K -47K -85K -145K -168K -126K -239.82K -293.9K -8.05M -12.31M -12.3M -12.27M -4.58M
Cash Acquisitions
n/a n/a n/a n/a n/a -3.98M -17.34M -17.34M -17.34M -13.35M n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-86.59M -105.35M -115.73M -136.34M -122.12M -120.94M -88.63M -53.79M -67.55M -94.48M -73.27M -74.29M -49.12M -116.03K -7.59M -61.34M -123.46M -128.54M
Sales Maturities Of Investments
197.43M 111.39M 87.34M 86.37M 75.34M 81.84M 102.41M 76.54M 60.56M 34.56M n/a 25.02M 43.71M 76.51M 107.43M 99.43M 95.22M 73.62M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a 13.35M 14.37M -10.97M -59.92M -73.27M -74.3M -49M -132.5K -194.54K -229.22K -204.67K -181.12K
Investing Cash Flow
110.84M 6.03M -28.39M -49.98M -46.77M -39.09M 13.73M 22.67M -7.13M -60.09M -73.4M -49.51M -5.7M 68.35M 87.52M 25.79M -40.51M -59.49M
Debt Repayment
14.6M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
170K 170K n/a n/a n/a n/a n/a -125K -125K -125K -125K n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
9.42M 9.48M 9.85M -576K -713K -756K -763K -726K -561K -3.03M 477K 13.01M 12.86M 15.45M 12.52M 144.97K 136.29M 168.2M
Financial Cash Flow
96.71M 44.42M 10.04M 72.71M 73.03M 86.15M 86.12M 13.32M 44.79M 53.31M 56.78M 69.36M 37.42M 33.86M 65.1M 75.27M 211.29M 247.81M
Net Cash Flow
125.98M -29.87M -98.19M -55.38M -45.22M -25.7M 24.03M -40.6M -33.5M -75.26M -79.2M -47.4M -38.24M 30.01M 74.38M 31.37M 109.36M 138.66M
Free Cash Flow
-81.58M -80.33M -79.85M -78.12M -71.48M -72.76M -75.86M -76.67M -71.29M -68.64M -62.71M -67.49M -70.27M -80.24M -90.55M -81.99M -73.68M -54.23M